Smoking and human papillomavirus infection: Pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys

International Journal of Epidemiology

Volumn 37, Issue 3, 2008, Pages 536-546

  Vaccarella, Salvatore ^a   Herrero, Rolando ^b   Snijders, Peter J F ^c   Dai, Min ^a   Thomas, Jaiye O ^d   Hieu, Nguyen Trong ^e   Ferreccio, Catterina ^f   Matos, Elena ^g   Posso, Hector ^h   De Sanjosé, Silvia ⁱ   Shin, Hai Rim ^j   Sukvirach, Sukhon ^k   Lazcano Ponce, Eduardo ^l   Muñoz, Nubia ^h   Meijer, Chris J L M ^c   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF IBADAN   (Nigeria)

^e Hung Vuong Hospital   (Viet Nam)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^h Instituto Nacional de Cancerología   (Colombia)

ⁱ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^j National Cancer Center   (South Korea)

^k NATIONAL CANCER INSTITUTE   (Thailand)

^l INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

more..

Author keywords

Epidemiology; General population; Human papillomavirus; Risk factors; Smoking

Indexed keywords

DISEASE PREVALENCE; DOSE-RESPONSE RELATIONSHIP; EPIDEMIOLOGY; HEALTH RISK; INFECTIOUS DISEASE; RISK FACTOR; SMOKING;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SMOKING; SMOKING HABIT; UTERINE CERVIX CANCER; VERRUCOUS CARCINOMA; WART VIRUS; WOMEN'S HEALTH;

HUMAN PAPILLOMAVIRUS;

EID: 44949092421     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn033     Document Type: Article

References (56)

1. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 90: Human papillomaviruses. Lyon: International Agency for Research on Cancer, 2007.
2. Vaccarella S, Franceschi S, Herrero R et al. Sexual behaviour, condom use, and human papillomavirus: Pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33.
3. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003;31:14-19.
5. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 83: Tobacco Smoke and Involuntary Smoking. Lyon: IARC Press, 2004.
6. International Collaboration of Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118:1481-95.
7. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157 218-26.
8. Ley C, Bauer HM, Reingold A et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:997-1003.
9. Bauer HM, Hildesheim A, Schiffman MH et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-78.
10. Olsen AO, Dillner J, Skrondal A, Magnus P. Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology 1998;9:346-49.
11. Herrero R, Castle PE, Schiffman M et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005;191:1796-807.
12. Sellors JW, Mahony JB, Kaczorowski J et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000; 163:503-8.
13. Giuliano AR, Papenfuss M, Abrahamsen M et al. Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10:1129-36.
14. Muñoz, N, Mendez F, Posso H et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077-87.
15. Sellors JW, Karwalajtys TL, Kaczorowski J et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003;168:421-25.
16. Moscicki AB, Hills N, Shiboski S et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002.
17. Kjaer SK, van den Brule AJ, Bock JE et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: Are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
18. Deacon JM, Evans CD, Yule R et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000;83:1565-72.
19. Hildesheim A, Schiffman MH, Gravitt PE et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
20. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-28.
21. Giuliano AR, Sedjo RL, Roe DJ et al. Clearance of oncogenic human papillomavirus (HPV) infection: Effect of smoking (United States). Cancer Causes Control 2002;13:839-46.
22. Molano M, van den Brule A, Plummer M et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: A population-based, 5-year follow-up study. Am J Epidemiol 2003;158:486-94.
23. Harris TG, Kulasingam SL, Kiviat NB et al. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol 2004;159:834-42.
24. Richardson H, Abrahamowicz M, Tellier PP et al. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev 2005;14:1149-56.
25. Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Van Assche FA. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995;39 34-38.
26. Poppe WA, Peeters R, Drijkoningen M et al. Cervical cotinine and macrophage-Langerhans cell density in the normal human uterine cervix. Gynecol Obstet Invest 1996;41:253-59.
27. Barton SE, Maddox PH, Jenkins D, Edwards R, Cuzick J, Singer A. Effect of cigarette smoking on cervical epithelial immunity: A mechanism for neoplastic change? Lancet 1988;2:652-54.
28. de Jong A, van Poelgeest MI, van der Hulst JM et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 2004;64:5449-55.
29. Evans EM, Man S, Evans AS, Borysiewicz LK. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res 1997;57:2943-50.
30. Herrero R, Brinton LA, Reeves WC et al. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 1989;81 205-11.
31. Anh PTH, Hieu NT, Herrero R et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104 213-20.
32. Sukvirach S, Smith JS, Tunsakul S et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246-56.
33. Shin HR, Lee DH, Herrero R et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103:413-21.
34. de Sanjosé S, Almirall R, Lloveras B et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;30:788-93.
35. Lazcano-Ponce E, Herrero R, Muñoz N et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
36. Matos E, Loria D, Amestoy GM et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: A population-based study. Sex Transm Dis 2003;30:593-99.
37. Ferreccio C, Prado RB, Luzoro AV et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004;13 2271-76.
38. Molano M, Posso H, Weiderpass E et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
39. Thomas JO, Herrero R, Omigbodun AA et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 2004;90:638-45.
40. Dai M, Bao YP, Li N et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: A population-based study. Br J Cancer 2006;95:96-101.
41. Franceschi S, Rajkumar R, Snijders PJF et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005;92 601-6.
42. Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJF, Meijer CJLM, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33 901-5.
43. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJLM, Snijders PJF. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-87.
44. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-27.
45. Qu W, Jiang G, Cruz Y et al. PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-10.
46. Ribes JA, Hayes M, Smith A, Winters JL, Baker DJ. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics. J Clin Microbiol 2001;39:3740-42.
47. Easton DF, Peto J, Babiker AG. Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991;10:1025-35.
48. Plummer M. Improved estimates of floating absolute risk, Stat. Med 2004;23:93-104.
49. Muñoz N, Bosch FX, de Sanjosé S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
50. Vaccarella S, Herrero R, Dai M et al. Reproductive factors, oral contraceptive use and HPV infection: Pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2006;15 2148-53.
51. Ferson M, Edwards A, Lind A, Milton GW, Hersey P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979;23:603-9.
52. Minkoff H, Feldman JG, Strickler HD et al. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. J Infect Dis 2004;189:1821-28.
53. sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC, Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-49.
54. Koshiol J, Schroeder J, Jamieson DJ et al. Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol 2006;164:176-83.
55. Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005;14:1528-33.
56. Szarewski A, Jarvis MJ, Sasieni P et al. Effect of smoking cessation on cervical lesion size. Lancet 1996;347:941-43.